CAROL VADIEE: Open Payments
NPI 1790740496 · CHALMETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 30 payments from 10 companies in 2025. Trend: 2023 $1,294 · 2024 $652 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $270 |
| AstraZeneca Pharmaceuticals LP | 6 | $223 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $120 |
| Corcept Therapeutics | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Amgen Inc. | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Exact Sciences Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
Products named: Kerendia, VRAYLAR, AIRSUPRA, UBRELVY, QULIPTA, FARXIGA, BREZTRI, Korlym.
Industry payments across LA — which companies pay providers there.
